What is thyroid ablation?

Thyroid ablation uses targeted heat or alcohol to destroy the cells inside a thyroid nodule, leaving the rest of the gland untouched. Over the following months, the body absorbs the treated tissue and the nodule gradually shrinks. There are several techniques, and your team chooses based on your nodule:

• Radiofrequency ablation (RFA) — the most common technique. A thin electrode delivers gentle heat to the nodule under live ultrasound guidance.
• Microwave ablation (MWA) — similar concept using microwave energy, sometimes preferred for larger nodules.
• Ethanol ablation (PEI, percutaneous ethanol injection) — preferred for thyroid nodules that are mostly cysts. The fluid is drained and a small amount of medical-grade alcohol is instilled to keep the cyst from refilling.
• Laser ablation — uses thin laser fibers, available in selected centers.

All four are performed under ultrasound, with no incision and no general anesthesia.

An alternative to surgery

Thyroid surgery — thyroid lobectomy (removing half the gland) or total thyroidectomy (removing the whole gland) — is well-established and remains the right choice for many patients, especially when there’s concern for cancer beyond the smallest microcarcinomas or when the nodule is too large or anatomically complex for ablation. But surgery comes with the realities of any operation: general anesthesia, an incision in the front of the neck, a small risk of voice change, and — after total thyroidectomy — a daily dose of levothyroxine for the rest of your life.

Ablation is different. It is performed under local anesthesia, often with light sedation. There is no incision, no thyroid removed, and most patients keep normal thyroid function and never need replacement medication. For benign nodules, autonomously functioning (toxic) nodules causing hyperthyroidism, and recurrent thyroid cysts that keep refilling after aspiration, ablation is now established care in international guidelines from the Korean Society of Thyroid Radiology, the European Thyroid Association, and AACE.^1,2

What the day looks like

You’ll come to the outpatient suite in the morning. After local anesthesia and light sedation, an ultrasound probe is placed on your neck. A thin needle electrode is guided through a small puncture in the skin into the nodule itself. The energy is delivered in small zones across the nodule, with the team carefully protecting the surrounding thyroid, the nerve to the voice box, and the tiny parathyroid glands beside the thyroid. The procedure takes 30 to 60 minutes. Most patients walk out the same day.

You may feel a sensation of warmth or pressure during the treatment. Afterward, mild neck soreness and a small amount of bruising at the puncture site are normal and resolve over a few days with over-the-counter medication. There is no scar.

What to expect over time

The shrinkage happens gradually. Compressive symptoms — pressure, swallowing difficulty, voice change — typically begin to ease in the first weeks. On follow-up ultrasound, most benign nodules are about 50 percent smaller at 6 months and 70 to 80 percent smaller at 12 months, with continued reduction over the following year or two.^3,4 For autonomously functioning nodules, thyroid function tests usually normalize over the same window. The procedure can safely be repeated if a nodule regrows.

Who is a good candidate?

Ablation is most appropriate for patients with a benign thyroid nodule confirmed on ultrasound (typically TI-RADS 2–3 or compatible) and on at least one — usually two — fine-needle aspiration cytology results read as benign (Bethesda II), where the nodule is causing compressive symptoms, cosmetic concern, or hyperthyroidism (in the case of a toxic adenoma). Recurrent thyroid cysts that keep refilling after one or more aspirations are excellent candidates for ethanol ablation. There is also growing evidence for ablation in selected low-risk papillary microcarcinoma in patients who would otherwise be candidates for active surveillance, and in selected post-thyroidectomy locoregional recurrences. Candidacy is always confirmed jointly with your endocrinologist or endocrine surgeon.

What is thyroid ablation?

Thyroid ablation uses targeted heat or alcohol to destroy the cells inside a thyroid nodule, leaving the rest of the gland untouched. Over the following months, the body absorbs the treated tissue and the nodule gradually shrinks. There are several techniques, and your team chooses based on your nodule:

• Radiofrequency ablation (RFA) — the most common technique. A thin electrode delivers gentle heat to the nodule under live ultrasound guidance.
• Microwave ablation (MWA) — similar concept using microwave energy, sometimes preferred for larger nodules.
• Ethanol ablation (PEI, percutaneous ethanol injection) — preferred for thyroid nodules that are mostly cysts. The fluid is drained and a small amount of medical-grade alcohol is instilled to keep the cyst from refilling.
• Laser ablation — uses thin laser fibers, available in selected centers.

All four are performed under ultrasound, with no incision and no general anesthesia.

An alternative to surgery

Thyroid surgery — thyroid lobectomy (removing half the gland) or total thyroidectomy (removing the whole gland) — is well-established and remains the right choice for many patients, especially when there’s concern for cancer beyond the smallest microcarcinomas or when the nodule is too large or anatomically complex for ablation. But surgery comes with the realities of any operation: general anesthesia, an incision in the front of the neck, a small risk of voice change, and — after total thyroidectomy — a daily dose of levothyroxine for the rest of your life.

Ablation is different. It is performed under local anesthesia, often with light sedation. There is no incision, no thyroid removed, and most patients keep normal thyroid function and never need replacement medication. For benign nodules, autonomously functioning (toxic) nodules causing hyperthyroidism, and recurrent thyroid cysts that keep refilling after aspiration, ablation is now established care in international guidelines from the Korean Society of Thyroid Radiology, the European Thyroid Association, and AACE.^1,2

What the day looks like

You’ll come to the outpatient suite in the morning. After local anesthesia and light sedation, an ultrasound probe is placed on your neck. A thin needle electrode is guided through a small puncture in the skin into the nodule itself. The energy is delivered in small zones across the nodule, with the team carefully protecting the surrounding thyroid, the nerve to the voice box, and the tiny parathyroid glands beside the thyroid. The procedure takes 30 to 60 minutes. Most patients walk out the same day.

You may feel a sensation of warmth or pressure during the treatment. Afterward, mild neck soreness and a small amount of bruising at the puncture site are normal and resolve over a few days with over-the-counter medication. There is no scar.

What to expect over time

The shrinkage happens gradually. Compressive symptoms — pressure, swallowing difficulty, voice change — typically begin to ease in the first weeks. On follow-up ultrasound, most benign nodules are about 50 percent smaller at 6 months and 70 to 80 percent smaller at 12 months, with continued reduction over the following year or two.^3,4 For autonomously functioning nodules, thyroid function tests usually normalize over the same window. The procedure can safely be repeated if a nodule regrows.

Who is a good candidate?

Ablation is most appropriate for patients with a benign thyroid nodule confirmed on ultrasound (typically TI-RADS 2–3 or compatible) and on at least one — usually two — fine-needle aspiration cytology results read as benign (Bethesda II), where the nodule is causing compressive symptoms, cosmetic concern, or hyperthyroidism (in the case of a toxic adenoma). Recurrent thyroid cysts that keep refilling after one or more aspirations are excellent candidates for ethanol ablation. There is also growing evidence for ablation in selected low-risk papillary microcarcinoma in patients who would otherwise be candidates for active surveillance, and in selected post-thyroidectomy locoregional recurrences. Candidacy is always confirmed jointly with your endocrinologist or endocrine surgeon.